Putnikv Dose India Price News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UPDATED: May 25, 2021 05:10 IST
Sputnik V was given emergency use authorisation by the Indian government on April 12 this year. (Photo: Reuters)
The Russian Direct Investment Fund (RDIF) has started the production of Sputnik V Covid-19 vaccine in India in collaboration with domestic pharma major Panacea Biotec. The joint venture is going to produce 100 million doses per year of Sputnik V in India and is expected to undergo full-scale production this summer, a joint statement issued on Monday said.
RDIF, a Russian sovereign wealth fund that markets the vaccine internationally, in April had announced a collaboration with Panacea Biotec. The first batch of the vaccine will be produced at Panacea Biotec s facilities at Baddi in Himachal Pradesh. This batch will then be shipped to Russia s Gamaleya Center for quality control , the joint statement said. ....

Andhra Pradesh , Himachal Pradesh , Oxford Astrazeneca , Kirill Dmitriev , Rajesh Jain , Serum Institute Of India Covishield , Russia Gamaleya Center , Russian Direct Investment Fund , Panacea Biotec , Gamaleya Center , Bharat Biotech , Serum Institute , Sputnik V , Sputnikv Vaccine In India , Sputnikv India Production , Sputnikv Vaccine Efficacy , Putnikv Dose India Price , India Covid 19 News , ஆந்திரா பிரதேஷ் , இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , ரஷ்ய நேரடி முதலீடு நிதி , சஞ்சீவி பயோடெக் , பாரத் பயோடெக் , சீரம் நிறுவனம் , ஸ்பட்நிக் வ் ,